Raymond James Financial Services Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.9M | Buy |
61,783
+4,352
| +8% | +$204K | ﹤0.01% | 1523 |
|
|
2024
Q2 | $3.1M | Buy |
57,431
+11,391
| +25% | +$615K | ﹤0.01% | 1424 |
|
|
2024
Q1 | $3.14M | Buy |
46,040
+6,623
| +17% | +$451K | ﹤0.01% | 1398 |
|
|
2023
Q4 | $2.47M | Buy |
39,417
+6,039
| +18% | +$378K | ﹤0.01% | 1459 |
|
|
2023
Q3 | $1.52M | Buy |
33,378
+5,948
| +22% | +$270K | ﹤0.01% | 1661 |
|
|
2023
Q2 | $1.54M | Sell |
27,430
-1,937
| -7% | -$109K | ﹤0.01% | 1663 |
|
|
2023
Q1 | $1.33M | Buy |
29,367
+2,102
| +8% | +$95.1K | ﹤0.01% | 1726 |
|
|
2022
Q4 | $1.11M | Buy |
27,265
+985
| +4% | +$40K | ﹤0.01% | 1772 |
|
|
2022
Q3 | $1.72M | Buy |
26,280
+5,498
| +26% | +$359K | ﹤0.01% | 1503 |
|
|
2022
Q2 | $1.26M | Sell |
20,782
-3,568
| -15% | -$217K | ﹤0.01% | 1692 |
|
|
2022
Q1 | $1.53M | Sell |
24,350
-13,140
| -35% | -$825K | ﹤0.01% | 1671 |
|
|
2021
Q4 | $2.84M | Buy |
37,490
+8,018
| +27% | +$608K | 0.01% | 1312 |
|
|
2021
Q3 | $3.3M | Buy |
29,472
+9,564
| +48% | +$1.07M | 0.01% | 1201 |
|
|
2021
Q2 | $3.22M | Sell |
19,908
-7,834
| -28% | -$1.27M | 0.01% | 1201 |
|
|
2021
Q1 | $3.38M | Buy |
27,742
+6,044
| +28% | +$736K | 0.01% | 1104 |
|
|
2020
Q4 | $3.32M | Buy |
21,698
+6,431
| +42% | +$985K | 0.01% | 1018 |
|
|
2020
Q3 | $1.28M | Buy |
15,267
+2,560
| +20% | +$214K | ﹤0.01% | 1398 |
|
|
2020
Q2 | $934K | Buy |
12,707
+1,883
| +17% | +$138K | ﹤0.01% | 1530 |
|
|
2020
Q1 | $459K | Buy |
10,824
+37
| +0.3% | +$1.57K | ﹤0.01% | 1606 |
|
|
2019
Q4 | $657K | Buy |
10,787
+1,673
| +18% | +$102K | ﹤0.01% | 1797 |
|
|
2019
Q3 | $374K | Buy |
9,114
+611
| +7% | +$25.1K | ﹤0.01% | 2090 |
|
|
2019
Q2 | $400K | Buy |
8,503
+1,102
| +15% | +$51.8K | ﹤0.01% | 2072 |
|
|
2019
Q1 | $264K | Sell |
7,401
-110
| -1% | -$3.92K | ﹤0.01% | 2335 |
|
|
2018
Q4 | $215K | Sell |
7,511
-5,503
| -42% | -$158K | ﹤0.01% | 2206 |
|
|
2018
Q3 | $577K | Hold |
13,014
| – | – | ﹤0.01% | 1809 |
|
|
2018
Q2 | $765K | Buy |
+13,014
| New | +$765K | ﹤0.01% | 1594 |
|